Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects

Clinical trial NCT01646814 · COMPLETED

Trial details

NCT number: NCT01646814
Sponsor: PLx Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastroduodenal Ulceration

Start date: 2012-09-01
Primary completion: 2013-06-01
Enrollment: 247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.